Patients without diabetes remission at three years after RYGB included in the study suffered from NAFLD, which could explain the higher ratio of the Adpn/Lep ratio without T2D remission. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.